CGH
ABBV icon

Crossmark Global Holdings’s AbbVie ABBV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$8.46M Sell
45,592
-717
-2% -$133K 0.14% 182
2025
Q1
$9.7M Sell
46,309
-31,083
-40% -$6.51M 0.17% 148
2024
Q4
$13.8M Sell
77,392
-3,435
-4% -$610K 0.25% 92
2024
Q3
$16M Buy
80,827
+1,045
+1% +$206K 0.28% 85
2024
Q2
$13.7M Sell
79,782
-4,199
-5% -$720K 0.26% 88
2024
Q1
$15.3M Sell
83,981
-11,161
-12% -$2.03M 0.29% 78
2023
Q4
$14.7M Buy
95,142
+1,738
+2% +$269K 0.31% 75
2023
Q3
$13.9M Buy
93,404
+588
+0.6% +$87.5K 0.32% 74
2023
Q2
$14M Buy
92,816
+3,934
+4% +$593K 0.3% 77
2023
Q1
$14.2M Sell
88,882
-84,689
-49% -$13.5M 0.33% 67
2022
Q4
$28.1M Sell
173,571
-12,693
-7% -$2.05M 0.7% 17
2022
Q3
$25M Buy
186,264
+599
+0.3% +$80.4K 0.69% 19
2022
Q2
$28.4M Buy
185,665
+61,058
+49% +$9.35M 0.74% 16
2022
Q1
$20.2M Buy
124,607
+481
+0.4% +$78K 0.45% 39
2021
Q4
$16.8M Buy
124,126
+8,656
+7% +$1.17M 0.37% 58
2021
Q3
$12.5M Buy
115,470
+1,953
+2% +$211K 0.29% 84
2021
Q2
$12.8M Sell
113,517
-86,390
-43% -$9.73M 0.3% 80
2021
Q1
$21.6M Sell
199,907
-3,432
-2% -$371K 0.54% 31
2020
Q4
$21.8M Sell
203,339
-2,359
-1% -$253K 0.55% 30
2020
Q3
$18M Buy
205,698
+66,801
+48% +$5.85M 0.51% 32
2020
Q2
$13.6M Buy
138,897
+21,747
+19% +$2.14M 0.4% 47
2020
Q1
$8.93M Sell
117,150
-75,438
-39% -$5.75M 0.32% 86
2019
Q4
$17.1M Sell
192,588
-774
-0.4% -$68.5K 0.47% 39
2019
Q3
$14.6M Sell
193,362
-7,089
-4% -$537K 0.43% 50
2019
Q2
$14.6M Sell
200,451
-5,871
-3% -$427K 0.41% 48
2019
Q1
$16.6M Sell
206,322
-1,499
-0.7% -$121K 0.47% 38
2018
Q4
$19.2M Sell
207,821
-5,943
-3% -$548K 0.59% 28
2018
Q3
$20.2M Sell
213,764
-266
-0.1% -$25.2K 0.51% 35
2018
Q2
$19.8M Sell
214,030
-6,299
-3% -$584K 0.53% 27
2018
Q1
$20.9M Sell
220,329
-3,833
-2% -$363K 0.54% 28
2017
Q4
$21.7M Buy
224,162
+11,994
+6% +$1.16M 0.52% 29
2017
Q3
$18.9M Buy
+212,168
New +$18.9M 0.49% 35
2016
Q3
$18.9M Buy
+212,168
New +$18.9M 0.49% 35